Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32−0.00 (-1.25%)
Close on Nov 17, 2026Market cap $11.51MP/E –Yield –
Dyadic International profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Dyadic International's profit margin for the twelve months ending Sep 30, 2026 was -226.9%. For fiscal 2025 it was -238.3%, against -166.2% the year before. The highest annual figure on record is -166.2% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -238.3% | −72.1 |
| FY2024 | Dec 31, 2024 | -166.2% | +68.2 |
| FY2023 | Dec 31, 2023 | -234.4% | +97.8 |
| FY2022 | Dec 31, 2022 | -332.2% | +211.5 |
| FY2021 | Dec 31, 2021 | -543.7% | +38.4 |
| FY2020 | Dec 31, 2020 | -582.1% | −87.9 |
| FY2019 | Dec 31, 2019 | -494.2% | −54.8 |
| FY2018 | Dec 31, 2018 | -439.4% | −157.8 |
| FY2017 | Dec 31, 2017 | -281.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -302.2% | −132.5 |
| Q2 FY2026 | Jun 30, 2026 | -221.0% | −35.4 |
| Q1 FY2026 | Mar 31, 2026 | -175.9% | +339.2 |
| Q4 FY2025 | Dec 31, 2025 | -277.1% | −87.4 |
| Q3 FY2025 | Sep 30, 2025 | -169.7% | −159.3 |
| Q2 FY2025 | Jun 30, 2025 | -185.6% | +344.4 |
| Q1 FY2025 | Mar 31, 2025 | -515.2% | +85.4 |
| Q4 FY2024 | Dec 31, 2024 | -189.7% | +112.0 |
| Q3 FY2024 | Sep 30, 2024 | -10.4% | +396.2 |
| Q2 FY2024 | Jun 30, 2024 | -530.0% | −272.8 |
| Q1 FY2024 | Mar 31, 2024 | -600.6% | −502.8 |
| Q4 FY2023 | Dec 31, 2023 | -301.8% | −13.2 |
| Q3 FY2023 | Sep 30, 2023 | -406.6% | −200.9 |
| Q2 FY2023 | Jun 30, 2023 | -257.2% | +242.1 |
| Q1 FY2023 | Mar 31, 2023 | -97.8% | +286.5 |
| Q4 FY2022 | Dec 31, 2022 | -288.6% | +1056.4 |
| Q3 FY2022 | Sep 30, 2022 | -205.7% | +41.9 |
| Q2 FY2022 | Jun 30, 2022 | -499.3% | −88.8 |
| Q1 FY2022 | Mar 31, 2022 | -384.3% | −383.5 |
| Q4 FY2021 | Dec 31, 2021 | -1345.0% | −778.4 |
| Q3 FY2021 | Sep 30, 2021 | -247.5% | +352.8 |
| Q2 FY2021 | Jun 30, 2021 | -410.4% | +95.3 |
| Q1 FY2021 | Mar 31, 2021 | -0.7% | +701.4 |
| Q4 FY2020 | Dec 31, 2020 | -566.7% | −165.3 |
| Q3 FY2020 | Sep 30, 2020 | -600.3% | −226.6 |
| Q2 FY2020 | Jun 30, 2020 | -505.7% | +183.9 |
| Q1 FY2020 | Mar 31, 2020 | -702.1% | −161.7 |
| Q4 FY2019 | Dec 31, 2019 | -401.4% | −326.8 |
| Q3 FY2019 | Sep 30, 2019 | -373.7% | +211.8 |
| Q2 FY2019 | Jun 30, 2019 | -689.7% | +300.3 |
| Q1 FY2019 | Mar 31, 2019 | -540.4% | +568.1 |
| Q4 FY2018 | Dec 31, 2018 | -74.6% | – |
| Q3 FY2018 | Sep 30, 2018 | -585.4% | – |
| Q2 FY2018 | Jun 30, 2018 | -989.9% | – |
| Q1 FY2018 | Mar 31, 2018 | -1108.5% | – |
See a number that looks wrong?